Stock Information

 

In this section you will find detailed information regarding the Evotec SE share, ranging from basic share data over stock charts, shareholder structure, our financial analysts, our auditors to our dividend policy.  

 

Basic Share Data

Listing on Frankfurt Stock Exchange (XETRA)
Listing NASDAQ, New York
Security identification numbers
 
Ordinary bearer shares
ISIN: DE0005664809
 

American Depositary Shares (“ADSs”)
ISIN:
US30050E1055

Ticker symbol

Frankfurt Stock Exchange: EVT


NASDAQ: EVO

Bloomberg Xetra: EVT GY Equity

Reuters Xetra: EVTG.DE

Stock exchange

Frankfurt Stock Exchange
NASDAQ New York
Segment
Prime Standard
Global Select Market
Index
MDAX, TecDAX, Prime All Share, LTecDAX, Technology All Share, CDAX
n/a
Designated Sponsor
ODDO SEYDLER BANK AG
Paying agent
Deutsche Bank AG, Frankfurt am Main
J.P. Morgan
Number of shares issued
175,412,241 ordinary bearer shares
20,000,000 ADSs (10,000,000 ordinary shares)

Nominal capital

€ 175,412,241
€ 175,412,241
Security identification numbers
 
Listing on Frankfurt Stock Exchange (XETRA)
Ordinary bearer shares
ISIN: DE0005664809
 
Listing NASDAQ, New York

American Depositary Shares (“ADSs”)
ISIN:
US30050E1055

Ticker symbol

Listing on Frankfurt Stock Exchange (XETRA)

Frankfurt Stock Exchange: EVT


Listing NASDAQ, New York

NASDAQ: EVO

Bloomberg Xetra: EVT GY Equity

Reuters Xetra: EVTG.DE

Stock exchange

Listing on Frankfurt Stock Exchange (XETRA) Frankfurt Stock Exchange
Listing NASDAQ, New York NASDAQ New York
Segment
Listing on Frankfurt Stock Exchange (XETRA) Prime Standard
Listing NASDAQ, New York Global Select Market
Index
Listing on Frankfurt Stock Exchange (XETRA) MDAX, TecDAX, Prime All Share, LTecDAX, Technology All Share, CDAX
Listing NASDAQ, New York n/a
Designated Sponsor
Listing on Frankfurt Stock Exchange (XETRA) ODDO SEYDLER BANK AG
Listing NASDAQ, New York
Paying agent
Listing on Frankfurt Stock Exchange (XETRA) Deutsche Bank AG, Frankfurt am Main
Listing NASDAQ, New York J.P. Morgan
Number of shares issued
Listing on Frankfurt Stock Exchange (XETRA) 175,412,241 ordinary bearer shares
Listing NASDAQ, New York 20,000,000 ADSs (10,000,000 ordinary shares)

Nominal capital

Listing on Frankfurt Stock Exchange (XETRA) € 175,412,241
Listing NASDAQ, New York € 175,412,241

Listing on NASDAQ

Since November 2021 Evotec SE is listed on NASDAQ (Ticker Symbol: EVO).

Please find all further information regarding the NASDAQ listing as well as al published filings of Evotec SE under the following link:

Link to SEC/EDGAR

Stock Price & Chart

Shareholder structure

On 15 November 2021, the number of total voting rights amounts to 175,412,241.

Under the German Securities Trading Act (Wertpapierhandelsgesetz, WpHG), shareholders of a listed German company are required to notify the Company and the German Federal Financial Supervisory Authority (BaFin) of any change to the voting interest in Evotec SE whenever it reaches, exceeds or falls below specified thresholds (3%, 5%, 10%, 15%, 20%, 25%, 30%, 50% or 75% of the voting rights). Evotec’s voting rights announcements can be found at dgap.de.

Three shareholders, Novo Holdings A/S, T. Rowe Price Group Inc. and Mubadala Investment Company, currently hold more than 5% of the shares of Evotec SE. The free float according to the definition of the Frankfurt Stock Exchange is approx. 68% according to our estimates (Evotec: 11|2021).

 

Shareholder structure (in %)*

* Rounding differences may occur.

Evotec's Dividend Policy

The payment of dividends depends on Evotec’s financial situation and liquidity requirements, general market conditions, and statutory, tax and regulatory requirements. 

Evotec has never paid or declared any cash dividends on its ordinary shares, and does not anticipate paying any cash dividends on its ordinary shares in the foreseeable future. Evotec intends to retain all available funds and any future earnings and reinvest them in the company’s further growth strategy to better leverage longterm growth and sustainability.

Under German law, Evotec may pay dividends only from the distributable profit (Bilanzgewinn) reflected in its unconsolidated financial statements (as opposed to the consolidated financial statements for Evotec and its subsidiaries) prepared in accordance with the principles set forth in the German Commercial Code (Handelsgesetzbuch) and adopted by the Evotec Management Board (Vorstand) and the Supervisory Board (Aufsichtsrat), or, as the case may be, by the shareholders of Evotec in a general shareholders’ meeting. In addition, under German law Evotec may not pay dividends before annual profits exceed the losses carried forward. 

All of the shares represented by the ADSs offered in USA generally have the same dividend rights as all of Evotec's other outstanding shares.

 

TOP